FPT Launches MediSight Framework to Accelerate AI-Driven Healthcare and Life Sciences Innovation

• 16 Jul 2026
• TM Team
• 0 Comments

FPT announced the launch of MediSight, an AI-powered framework designed to help healthcare providers, medical device manufacturers, and pharmaceutical organizations accelerate digital transformation, strengthen regulatory compliance, and unlock actionable insights from healthcare data. The framework combines autonomous AI digital workers, healthcare-specific applications, and AI-augmented engineering capabilities to streamline clinical, operational, and regulatory workflows while enabling faster, data-driven decision-making across the healthcare value chain.

Built on FPT's FleziPT AI-first ecosystem and guided by CASAN, FPT's framework for progressing from AI experimentation to AI-native operations, MediSight enables healthcare and life sciences organizations to scale AI adoption across care delivery, business operations, and compliance functions. Combining AI agents, industry-specific accelerators, and AI-powered engineering capabilities, the solution converts fragmented healthcare information into structured intelligence, supporting faster innovation, stronger governance, and informed decision-making.

The framework is structured around three core layers. The Healthcare Insight Platform (HIP) provides a cloud-native, interoperable data foundation supporting standards such as HL7 v2, CDA, FHIR, and DICOM, with built-in capabilities for data mapping, de-identification, and clinical terminology standardization. MediSight Crew comprises autonomous AI agents, digital workers, and healthcare-focused assistants that support administrative, clinical, and compliance activities. MediSight Verse offers a growing portfolio of applications spanning clinic management, claims administration, virtual care, patient engagement, clinical trials, medical imaging, documentation, and healthcare analytics.

Designed for healthcare-grade security, MediSight supports industry requirements including HIPAA, HITRUST r2, and ISO 27001. The framework can be deployed across major cloud environments and integrated with leading healthcare systems, enabling greater data traceability, streamlined compliance processes, accelerated product development, and more efficient patient care.

Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences, FPT Corporation, stated: “The next phase of healthcare innovation demands systems that don't just store data, but actively reason through it. MediSight helps healthcare organizations reduce manual effort, improve decision-making speed, and scale digital health solutions more efficiently. By fusing autonomous AI agents with specialized clinical applications, we are helping digital health and pharma enterprises eliminate manual friction, reduce time-to-market for medical software, and elevate patient outcomes without compromising on strict regulatory standards."

The launch of MediSight further strengthens FPT's healthcare and life sciences portfolio. With nearly two decades of experience serving healthcare providers, pharmaceutical companies, and medical device manufacturers worldwide, FPT supports organizations in advancing operational efficiency and patient-centric care. FPT has attained key healthcare certifications and standards, including HITRUST r2, HIPAA-compliant, ISO 9001, ISO 13485, IEC 62304, HL7, and DICOM, reinforcing its capability to deliver solutions for highly regulated healthcare environments.